Nano-x Imaging LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
Nano-X Imaging Ltd. reports its fiscal year 2024 results, showcasing FDA clearances for its Nanox.ARC system and strategic moves towards global commercialization.
NASDAQ
Nanox Imaging's 2023 annual report reveals a company in strategic transition, balancing regulatory achievements with financial losses and a focus on refining its commercialization strategy.